References
- Bradburn, M. J., Deeks, J. J., Berlin, J. A., and Localio, A. R. (2007), “Much Ado About Nothing: A Comparison of the Performance of Meta-analytical Methods With Rare Events,” Statistics in Medicine, 26, 53–77. DOI: 10.1002/sim.2528.
- Cai, T., Parast, L., and Ryan, L. (2010), “Meta-analysis for Rare Events,” Statistics in Medicine, 29, 2078–2089. DOI: 10.1002/sim.3964.
- Diamond, G. A., Bax, L., and Kaul, S. (2007), “Uncertain Effects of Rosiglitazone on the Risk for Myocardial Infarction and Cardiovascular Death,” Annals of Internal Medicine, 147, 578–581. DOI: 10.7326/0003-4819-147-8-200710160-00182.
- Friedrich, J. O., Adhikari, N. K. J., and Beyene, J. (2007), “Inclusion of Zero Total Event Trials in Meta-analyses Maintains Analytic Consistency and Incorporates All Available Data,” BMC Medical Research Methodology, 7, DOI: 10.1186/1471–2288–7–5.
- Lane, P. W. (2011), “Meta-analysis of Incidence of Rare Events,” Statistical Methods in Medical Research, 22, 117–132. DOI: 10.1177/0962280211432218.
- National Diabetes Data Group (1995), Diabetes in America (2nd ed.), Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
- Hall, D. B., (2000), “Zero-Inflated Poisson and Binomial Regression With Random Effects: A Case Study,” Biometrics, 56, 1030–1039. DOI: 10.1111/j.0006-341X.2000.01030.x.
- Lambert, D. (1992), “Zero-Inflated Poisson Regression, With an Application to Defects in Manufacturing,” Technometrics, 34, 1–14. DOI: 10.2307/1269547.
- Liu, D., Liu, R. Y., and Xie, M. (2014), “Exact Meta-analysis Approach for Discrete Data and Its Application to 2 × 2 Tables With Rare Events,” Journal of American Statistical Association, 109, 1450–1465. DOI: 10.1080/01621459.2014.946318.
- Nissen, S. E., and Wolski, K. (2007), “Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death From Cardiocascular Causes,” The New England Journal of Medicine, 356, 2457–2471. DOI: 10.1056/NEJMoa072761.
- Sweeting, M. J., Sutton, A. J., and Lambert, P. C. (2004), “What to Add to Nothing? Use and Avoidance of Continuity Corrections in Meta-analysis of Sparse Data,” Statistics in Medicine, 23, 1351–1375. DOI: 10.1002/sim.1761.
- Tian, L., Cai, T., Pfeffer, M. A., Piankov, N., Cremieux, P.-Y., and Wei, L. J. (2009), “Exact and Efficient Inference Procedure for Meta-analysis and its Application to the Analysis of Independent 2 × 2 Tables with all Available Data but Without Artificial Continuity Correction,” Biostatistics, 10, 275–281. DOI: 10.1093/biostatistics/kxn034.
- Yusuf, S., Peto, R., Lewis, J., Collins, R., and Sleight, P. (1985), “Beta Blockade During and After Myocardial Infarction: An Overview of the Randomized Trials,” Progress in Cardiovascular Diseases, 27, 335–371. DOI: 10.1016/S0033-0620(85)80003-7.